17.03.27 – 18.03.27 • New York City, USA
Perturb 2027
CRISPR screens have become a primary discovery engine in modern biology as well as a key tool in drug discovery. Following the success of the first edition of Perturb, the second edition will take place in March of 2027 in NYC.
Join Myllia at Perturb 2027 – the second edition of the high-content CRISPR screening conference. The event will feature technologies that link CRISPR perturbation screens to high-content read-outs.
Visit Perturb 2027 for more information.
Registrations open September 15th 2026.
Scientific themes:
- CRISPR-based screening strategies
- Perturb-Seq & CROP-Seq methodologies
- Computational analysis and data interpretation
- AI models of human cells
- Imaging-based CRISPR screens
Confirmed speakers (in alphabetical order)
– Anshul Kundaje, Stanford University | US
– Brian Brown, Icahn School of Medicine | US
– Caroline Uhler, MIT | US
– Danwei Huangfu, Memorial Sloan Kettering Cancer Center | US
– Hani Godarzi, UCSF | US
– Jimmie Ye, Genentech | US
– Jonathan Pritchard, Stanford University | US
– Jonathan Weissman, MIT | US
– Julia Carnevale, UCSF | US
– Junyue Cao, The Rockefeller University | US
– Luke Gilbert, Arc Institute & UCSF | US
– Manuel Leonetti, Chan Zuckerberg Biohub | US
– Rahul Satija, New York Genome Center | US
– Thomas Norman, Memorial Sloan Kettering Cancer Center | US
– Tilmann Bürckstümmer, Myllia Biotechnology | AT
– Xin Jin, Scripps Research & HHMI | US